Morarka Finance Regulatory Approval

Financial Results

Morarka Finance Q2 FY27 Results: Net Profit ₹0.1 Cr, Down 90.9% YoY

Morarka Finance Ltd reported revenue from operations of ₹0.3 Cr (-81.2% YoY) and net profit of ₹0.1 Cr (-90.9% YoY) for Q2 FY27.

Key figure

Net profit ₹0.1 Cr · -90.9% YoY

Other Announcement

Morarka Finance Other Announcement

Morarka Finance Ltd has filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI LODR regulations.

Board Meeting Date

Morarka Finance Board Meeting Date

Morarka Finance scheduled a board meeting for 21 Oct 2026 to approve Q2 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.

Business Update

Morarka Finance Business Update

Morarka Finance plans to apply for NBFC deregistration following new RBI guidelines. The company intends to operate as an Unregistered Type I NBFC.

Financial Results

Morarka Finance Q1 FY27 Results: Net Profit ₹0.4 Cr, Up 300.0% YoY

Morarka Finance Ltd reported revenue from operations of ₹0.6 Cr (+200.0% YoY) and net profit of ₹0.4 Cr (+300.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.4 Cr · +300.0% YoY

Board Meeting Outcome

Morarka Finance Board Meeting Outcome

Morarka Finance board approved unaudited financial results for the quarter ended June 30, 2026. The board also approved seeking RBI de-registration to become an Unregistered Type I NBFC.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.